Recovery research fieldbook Evidence, not treatment advice
Recovery archive

Published recovery field note

MK-677 Protocol Guide — Path To Peptides

Complete MK-677 (Ibutamoren) research protocol: oral GH secretagogue dosing at 10-25mg daily, blood glucose monitoring, appetite management, cycle length, and stacking.

Context first

Study findings do not automatically establish clinical benefit, safety, dosing, or suitability for an individual.

Protocol Overview

Dosing Protocol

Standard

1-12+

25 mg

Before bed

Oral

Conservative

1-8

10-15 mg

Low-dose Long-term

1-24

10 mg

Key: No reconstitution needed. Take before bed to align with natural GH release and minimize waking appetite. Can take with or without food.

Administration

How to Take

Oral capsule or measured liquid

No injection required

Swallow with water before bed

Timing & Storage

Time: Before bed (preferred)

Consistency: Same time daily

Storage: Room temperature, away from light

Expected Timeline

Side Effects & Monitoring

Common

Increased appetite (significant)

Water retention / bloating

Vivid dreams / drowsiness

Numbness/tingling in hands

Elevated fasting blood glucose

Serious

Insulin resistance (prolonged use)

Significant edema

Joint pain from fluid shifts

Elevated prolactin (uncommon)

Critical: Monitor fasting blood glucose regularly. MK-677 can cause insulin resistance. Consider berberine or chromium for glucose management.

Stacking

Compatible

CJC-1295/Ipamorelin: Alternate days

BPC-157: Recovery support

Berberine: Blood glucose management

Cardarine: Metabolic offset

Notes

Monitor glucose closely with any stack

Avoid other GH secretagogues on same days

High-protein, moderate-carb diet recommended

Blood Work (Critical)

Metabolic (Priority)

Fasting glucose, HbA1c, fasting insulin, HOMA-IR

Baseline, Week 4, 8, 12

GH Axis

IGF-1

Baseline, Week 4, 8

Hormonal

Prolactin, cortisol

Baseline, Week 8

Basic

CBC, CMP, lipids

Related Tools

Related Resources

Connected topics

Follow this recovery question